Atlas Trials

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

Clinical trial NCT04999046 · COMPLETED

Trial details

NCT number
NCT04999046
Sponsor
NaviFUS Corporation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Drug Resistant EpilepsySeizureSeizure DisorderEpilepsy
Start date
2021-10-07
Primary completion
2024-05-13
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.